MYC and colorectal carcinoma: Two clinical studies demonstrated that preoperative neoadjuvant chemotherapy with 5-flurouracil (5-FU) in breast cancer patients or postoperative adjuvant chemotherapy in CRC patients with c-Myc amplification were associated with better therapeutic responses than in those with no amplification.